• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/18; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/18; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 364487
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Injury (2348); No Information (3190)
Event Date 08/03/2020
Event Type  Injury  
Event Description
An orsiro drug-eluting stent system was selected for treatment.During implantation the stent dislodged in the aorta.Patient was transferred to an emergency room.
 
Manufacturer Narrative
Combination product: yes the complaint instrument was not returned for a technical investigation.Therefore, no technical investigation on the subject could be performed.The corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.In addition, the angiographic material provided was reviewed.Review of the production documentation for the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent and the stent retention force of a defined amount of samples is tested from every lot.Review of the angiographic material showed the dislodged complaint stent which is entangled with its distal end at the proximal end of a previously implanted stent over the bifurcation towards the target lesion.The actual complaint event has not been recorded.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause could be determined.The root cause for the reported complaint event is therefore most likely related to the patients anatomy (previously implanted stent).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 2.25/18
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key10456671
MDR Text Key204453606
Report Number1028232-2020-03595
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130439023
UDI-Public7640130439023
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/28/2020
Device Model Number364487
Device Catalogue NumberSEE MODEL NO.
Device Lot Number11182420
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/24/2020
Initial Date FDA Received08/26/2020
Supplement Dates Manufacturer Received10/14/2020
Supplement Dates FDA Received10/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-